These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34494075)

  • 1. Public Health Unit notifications of hepatitis C and their follow-up in South Western Sydney, Australia.
    O'Brien ER; Whelan MC; Lama T; Levy M
    Public Health Res Pract; 2021 Sep; 31(3):. PubMed ID: 34494075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timely Hepatitis C RNA Testing and Treatment in the Era of Direct-Acting Antiviral Therapy among People with Hepatitis C in New South Wales, Australia.
    Yousafzai MT; Alavi M; Valerio H; Hajarizadeh B; Grebely J; Dore GJ
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The disposition of hepatitis C antibody-positive patients in an urban hospital.
    Putka B; Mullen K; Birdi S; Merheb M
    J Viral Hepat; 2009 Nov; 16(11):814-21. PubMed ID: 19842281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology of hepatitis C in Australia: notifications, treatment uptake and liver transplantations, 1997-2006.
    Gidding HF; Topp L; Middleton M; Robinson K; Hellard M; McCaughan G; Maher L; Kaldor JM; Dore GJ; Law MG
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1648-54. PubMed ID: 19798783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C care cascade before and during the direct-acting antiviral eras in New South Wales, Australia: A population-based linkage study.
    Yousafzai MT; Alavi M; Valerio H; Hajarizadeh B; Grebely J; Dore GJ
    J Viral Hepat; 2023 Mar; 30(3):250-261. PubMed ID: 36537024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
    Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ
    J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised controlled trial of active case management to link hepatitis C notifications to treatment in Tasmania, Australia: a study protocol.
    Marukutira T; Moore KP; Hellard M; Richmond J; Turner K; Pedrana AE; Melody S; Johnston FH; Owen L; Van Den Boom W; Scott N; Thompson A; Iser D; Spelman T; Veitch M; Stoové MA; Doyle J
    BMJ Open; 2022 Mar; 12(3):e056120. PubMed ID: 35338062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the hepatitis C cascade of care among people living with HIV in New South Wales, Australia: A data linkage study.
    Hosseini-Hooshyar S; Alavi M; Martinello M; Valerio H; Tillakeratne S; Matthews GV; Dore GJ
    J Viral Hepat; 2022 Apr; 29(4):271-279. PubMed ID: 35175671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decentralised hepatitis C testing and treatment in rural Cambodia: evaluation of a simplified service model integrated in an existing public health system.
    Zhang M; O'Keefe D; Craig J; Samley K; Bunreth V; Jolivet P; Balkan S; Marquardt T; Dousset JP; Le Paih M
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):371-380. PubMed ID: 33743883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aiming for elimination: Outcomes of a consultation pathway supporting regional general practitioners to prescribe direct-acting antiviral therapy for hepatitis C.
    Wade AJ; McCormack A; Roder C; McDonald K; Davies M; Scott N; Wardrop M; Athan E; Hellard ME
    J Viral Hepat; 2018 Sep; 25(9):1089-1098. PubMed ID: 29660212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pathways for patients with newly diagnosed hepatitis C - what actually happens.
    Irving WL; Smith S; Cater R; Pugh S; Neal KR; Coupland CA; Ryder SD; Thomson BJ; Pringle M; Bicknell M; Hippisley-Cox J
    J Viral Hepat; 2006 Apr; 13(4):264-71. PubMed ID: 16611193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C enhanced surveillance: results from a southeastern Sydney pilot program.
    Bateman-Steel CR; Smedley EJ; Kong M; Ferson MJ
    Public Health Res Pract; 2015 Mar; 25(2):e2521520. PubMed ID: 25848738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opportunistic assessment and treatment of people with hepatitis C virus infection admitted to hospital for other reasons: A prospective cohort study.
    Chiong F; Post J
    Int J Drug Policy; 2019 Mar; 65():50-55. PubMed ID: 30611857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The distribution and socioeconomic burden of Hepatitis C virus in South Australia: a cross-sectional study 2010-2016.
    Edmunds BL; Miller ER; Tsourtos G
    BMC Public Health; 2019 May; 19(1):527. PubMed ID: 31068170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Follow-up diagnostics, referral and follow-up of hepatitis B and C patients].
    Hofman R; Veldhuijzen IK; van der Lei J; Richardus JH
    Ned Tijdschr Geneeskd; 2018 Jan; 162():. PubMed ID: 30730118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000-2014).
    Waziry R; Grebely J; Amin J; Alavi M; Hajarizadeh B; George J; Matthews GV; Law M; Dore GJ
    J Hepatol; 2016 Dec; 65(6):1086-1093. PubMed ID: 27569777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic hepatitis B and C infection in children in New South Wales.
    Nightingale S; Stormon MO; Day AS; Webber MT; Ward KA; O'Loughlin EV
    Med J Aust; 2009 Jun; 190(12):670-3. PubMed ID: 19527200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCV microelimination strategies: An interventional study in diagnosed patients without access to the system.
    Guerra Veloz MF; Del Pino Bellido P; Cordero Ruiz P; Vega Rodriguez F; Bellido Muñoz F; Ramirez de Arellano E; Caunedo Álvarez A; Pascual Hernandez A; Carmona Soria I
    Liver Int; 2021 May; 41(5):928-933. PubMed ID: 33587789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C prevalence--a nationwide serosurvey.
    Amin J; Gidding H; Gilbert G; Backhouse J; Kaldor J; Dore G; Burgess M
    Commun Dis Intell Q Rep; 2004; 28(4):517-21. PubMed ID: 15745402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.